Advaxis raises $23 million, moves to NASDAQ

Immunotherapy company Advaxis Inc. (NASDAQ:ADXS) began trading on NASDAQ on Thursday after it raised $23 million through the sale of 5.8 million shares at $4 in a follow-on underwritten by Aegis Capital. The follow-on includes five-year warrants to purchase 2.9 million shares at $5. Advaxis, which ceased trading on OTCQB, was off $1.30 (26%) to $3.69 on Thursday. ...